Intercept Pharmaceuticals
Stock Forecast, Prediction & Price Target
Intercept Pharmaceuticals Financial Estimates
Intercept Pharmaceuticals Revenue Estimates
Intercept Pharmaceuticals EBITDA Estimates
Intercept Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2020 | 12/31/2021 | 12/31/2022 | 12/31/2025 | |||
Revenue
% change YoY
| $312.69M N/A | $363.46M 16.23% | $285.71M -21.39% | Avg: $361.49M Low: $335.68M High: $388.89M avg. 26.52% | |||
Net Income
% change YoY
| $-324.23M N/A | $-145.02M 55.27% | $115.17M 179.41% | Avg: $85.14M Low: $5.41M High: $93.39M avg. -26.07% | |||
EBITDA
% change YoY
| $-212.19M N/A | $-53.60M 74.73% | $-61.69M -15.09% | Avg: $-219.93M Low: $-204.23M High: $-236.60M avg. -256.49% | |||
EPS
% change YoY
| -$9.83 N/A | -$4.55 53.71% | $3.41 174.94% | Avg: $1.78 Low: $0.16 High: $2.76 avg. -47.69% | |||
Operating Expenses
% change YoY
| $523.97M N/A | $416.12M -20.58% | $352.94M -15.18% | Avg: $307.43M Low: $285.48M High: $330.72M avg. -12.89% | |||
FAQ
What is Intercept Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -26.07% in 2025-2025.
We have gathered data from 13 analysts. Their low estimate is 5.41M, average is 85.14M and high is 93.39M.
What is Intercept Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 26.52% in 2025-2025.
We have gathered data from 13 analysts. Their low revenue estimate is $335.68M, average is $361.49M and high is $388.89M.
What is Intercept Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -47.69% in 2025-2025.
We have gathered data from 13 analysts. Their low earnings per share estimate is $0.16, average is $1.78 and high is $2.76.
What is the best performing analyst?
In the last twelve months analysts have been covering Intercept Pharmaceuticals stock. The most successful analyst is Ed Arce whose win rate is 100%. He has correctly predicted 1/1 price targets.